SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Form 8.3 - CSR PLC - Replacement

28 Nov 2014 11:31

The issuer advises that the following replaces the BARCLAYS PLC Form 8.3 - CSR PLC announcement released on 27 November 2014 at 14.53 GMT.

The ticker information has been corrected to reference the information for the company CSR Plc instead of that of Consort Medical, which was erroneously included and should be disregarded.

All other details remain unchanged.

The full corrected version is shown below.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

CSR PLC

relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 26 November 2014
(f) Has the discloser previously disclosed, or are NO
they today disclosing, under the Code in respect
of any other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 4,887,599 2.94% 122,884 0.07%
(2) Derivatives (other than
options): 126 0.00% 3,362,849 2.03%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 4,887,725 2.94% 3,485,733 2.10%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 100 8.2350 GBP
ORD Purchase 248 8.2300 GBP
ORD Purchase 293 8.2275 GBP
ORD Purchase 376 8.2600 GBP
ORD Purchase 708 8.2500 GBP
ORD Purchase 1,118 8.2498 GBP
ORD Purchase 1,227 8.2467 GBP
ORD Purchase 1,263 8.2531 GBP
ORD Purchase 1,569 8.2450 GBP
ORD Purchase 2,328 8.2436 GBP
ORD Purchase 4,881 8.2405 GBP
ORD Purchase 5,347 8.2429 GBP
ORD Purchase 6,086 8.2603 GBP
ORD Purchase 6,097 8.2513 GBP
ORD Purchase 10,762 8.2394 GBP
ORD Sale 44 8.1950 GBP
ORD Sale 124 8.2300 GBP
ORD Sale 293 8.2275 GBP
ORD Sale 305 8.2500 GBP
ORD Sale 390 8.2600 GBP
ORD Sale 1,846 8.2400 GBP
ORD Sale 1,995 8.2514 GBP
ORD Sale 10,317 8.2364 GBP
ORD Sale 19,920 8.2405 GBP

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD SWAP Long 2,372 8.2382 GBP
ORD CFD Long 2,777 8.2386 GBP
ORD CFD Long 7,431 8.2362 GBP
ORD CFD Short 1,118 8.2498 GBP
ORD SWAP Short 1,482 8.2488 GBP
ORD SWAP Short 2,212 8.2479 GBP
ORD CFD Short 5,347 8.2429 GBP
ORD SWAP Short 6,086 8.2604 GBP
ORD CFD Short 5,235 8.2532 GBP

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 27 Nov 2014
Contact name: Sushil Vashisht
Telephone number: 0207 773 0744

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2014

Date   Source Headline
21st Jan 20113:00 pmRNSBlocklisting Interim Review
2nd Dec 20104:00 pmRNSBlocklisting Interim Review
2nd Dec 20107:05 amRNSBoard Appointment
2nd Dec 20107:00 amRNSInterim results for the 6 months ended 31 October
1st Dec 20103:00 pmRNSTotal Voting Rights
2nd Nov 20109:19 amRNSTotal Voting Rights
22nd Oct 20101:37 pmRNSHolding(s) in Company
22nd Oct 20101:37 pmRNSHolding(s) in Company
18th Oct 20107:00 amRNSKing Systems - New Digital Technology
14th Oct 20107:00 amRNSBlock Listing Application
21st Sep 20104:10 pmRNSDirector/PDMR Shareholding
20th Sep 201012:21 pmRNSHolding(s) in Company
20th Sep 201012:01 pmRNSBlocklisting Interim Review
15th Sep 20103:16 pmRNSResult of AGM
15th Sep 201011:40 amRNSInterim Management Statement
12th Aug 20102:48 pmRNSAnnual Financial Report & Notice of AGM
9th Aug 201011:58 amRNSDirector/PDMR Shareholding
5th Aug 201010:17 amRNSNotifications of Major Interests in Shares
3rd Aug 20102:38 pmRNSNotification of Transactions of Directors
30th Jul 201010:20 amRNSDirector/PDMR Shareholding
22nd Jul 20102:32 pmRNSHolding(s) in Company
21st Jul 20102:40 pmRNSBlocklisting Interim Review
12th Jul 20103:24 pmRNSHolding(s) in Company
24th Jun 20102:49 pmRNSHolding(s) in Company
18th Jun 20104:40 pmRNSSecond Price Monitoring Extn
18th Jun 20104:35 pmRNSPrice Monitoring Extension
17th Jun 20102:54 pmRNSBlocklisting Interim Review
17th Jun 20107:00 amRNSPreliminary Results
14th Jun 20109:41 amRNSBlocklisting Interim Review
3rd Jun 201011:02 amRNSNotice of date of Full Year Preliminary Results
24th May 20104:41 pmRNSSecond Price Monitoring Extn
24th May 20104:36 pmRNSPrice Monitoring Extension
21st May 20109:32 amRNSChange of Adviser
16th Apr 201012:53 pmRNSHolding(s) in Company
8th Apr 201012:58 pmRNSHolding(s) in Company
6th Apr 20103:57 pmRNSDirector/PDMR Shareholding
1st Apr 20102:08 pmRNSRule 8.3- (Consort Medical Plc)
31st Mar 20109:03 amRNSDirector/PDMR Shareholding
25th Mar 201010:19 amRNSRule 8.3- Consort Medical Plc
19th Mar 20103:11 pmRNSRule 8.3- Consort Medical plc
19th Mar 20102:38 pmRNSRule 8.3- Consort Medical PLC
19th Mar 20102:14 pmRNSBlocklisting Interim Review
19th Mar 20107:00 amRNSInterim Management Statement
18th Mar 20104:50 pmRNSOffer Talks Terminated
18th Mar 20101:54 pmRNSRule 8.3- Consort Medical PLC
17th Mar 20102:13 pmRNSRule 8.3- Consort Medical PLC
16th Mar 201011:49 amRNSRule 8.3- Consort Medical PLC
15th Mar 20102:57 pmRNSRule 8.3- Consort Medical PLC
12th Mar 20102:22 pmRNSRule 8.3- Consort Medical PLC
12th Mar 201010:12 amRNSRule 8.3- (Consort Medical Plc)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.